Trinity Biotech Cash Flow Statement (2009-2024) | TRIB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024
Operating Activities
Net Income (Quarter)	3.08M	1.76M	8.26M	-15.01M	4.39M	0.53M	-0.03M	-0.03M	0.79M	0.41M	-8.95M	-10.08M	0.50M	12.36M	-6.72M	-5.50M	-3.18M	-7.02M	-4.83M	-16.95M
Depreciation and Depletion (Quarter)						577.00		0.15M		47.00	0.48M	0.45M	351.00	305.00	173.00	0.00M	164.00	-65.00	260.00	0.32M
Share-based Compensation (Quarter)						312.00		0.15M		122.00	0.12M	1.32M	0.00M	975.00	738.00	-1.01M	812.00	114.00	250.00	0.14M
Deferred Taxes (Quarter)						655.00		-1.19M		-29.00		-0.02M				-0.00M				0.58M
Gains from Sales and Divestitures (Quarter)						0.01M		0.88M		519.00		3.03M				0.29M				0.96M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)											2.29M	-2.08M				0.29M
Cash from Restructuring (Quarter)																		0.00M	339.00
Non-cash Items (Quarter)	2.47M	2.78M	9.72M	14.84M	5.89M	-0.00M	2.23M	4.90M	-1.30M	995.00	-0.40M	3.06M		-0.01M	-0.00M	2.60M		-0.00M	-0.00M	7.01M
Change in Working Capital (Quarter)	-1.40M	1.47M	-2.55M	10.16M	1.83M	-3.15M	-1.78M	6.56M	-1.28M	-2.20M		0.17M
Change in Accured Expenses (Quarter)
Change in Taxes (Quarter)								0.40M				-0.01M				-0.07M				-0.23M
Cash from Operations (Quarter)								3.91M				2.29M	-0.01M	-7.13M		0.31M	-0.00M	-3.92M		3.58M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)														0.01M				446.00
Amortizatization of Intangibles (Quarter)						240.00		0.23M		214.00	0.27M	0.21M	251.00	179.00	56.00	0.46M	527.00	218.00	338.00	0.11M
Depreciation & Amortization (CF) (Quarter)						577.00		0.15M		47.00	0.48M	0.45M	351.00	305.00	173.00	0.00M	164.00	-65.00	260.00	0.32M
Investing Activities
Capital Expenditures (Quarter)						-389.00		-0.57M		-143.00	-0.32M	-0.47M			-0.13M	-0.25M				-0.16M
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Divestments (Quarter)															-0.27M
Cash from Investing Activities (Quarter)						-0.00M		-2.48M		-0.00M	-1.32M	-1.14M			-0.89M	-0.89M				-2.74M
Financing Activities
Cash from Financing Activities (Quarter)						-0.00M		-3.59M		0.00M	-2.37M	-1.84M			-2.43M	-1.77M				1.80M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)						95.00		0.17M		-153.00	-0.18M	0.03M			0.01M	-0.16M				-0.09M
Change in Cash (Quarter)	13.24M	15.57M	19.91M	27.33M	32.28M	-0.00M	27.48M	-1.73M	10.01M	594.00	-3.02M	-0.71M			-7.98M	-2.41M				2.42M
Beginning Cash Balance (Quarter)	16.40M	13.24M	15.57M	19.91M	27.33M	32.28M	28.62M	27.48M	25.91M			7.25M				6.26M				2.84M
Free Cash Flow (Quarter)						389.00		4.48M		143.00	0.32M	2.76M	-0.01M	-7.13M	0.13M	0.56M	-0.00M	-3.92M		3.74M
Net Cash Flow (Quarter)						-0.00M		-2.15M		0.00M	-3.70M	-0.70M	-0.01M	-7.13M	-3.32M	-2.35M	-0.00M	-3.92M		2.65M

Research Tools

Developers

Trinity Biotech Cash Flow Statement (2009-2024) | TRIB

Research Tools

Developers

Trinity Biotech Cash Flow Statement (2009-2024) | TRIB

Create an account

Sign In

Reset Password